Anti-BCMA CAR-T cells therapy for a patient with extremely high membrane BCMA expression: a case report
Sign Up to like & getrecommendations! Published in 2022 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2022-005403
Abstract: B cell maturation antigen (BCMA)-directed CAR-T cell therapy is a disruptive approach for treating relapsed/refractory multiple myeloma (R/R MM); however, optimization is necessary to maximize patient benefit. We report the case of a 61-year-old woman… read more here.
Keywords: bcma; expression; case; membrane bcma ... See more keywords